Genetically-engineered "all-in-one" vaccine platform for cancer immunotherapy.
Wu A, Chen Y, Wang H, Chang Y, Zhang M, Zhao P, Tang Y, Xu Q, Zhu Z, Cao Y, Huang Y.
Wu A, et al.
Acta Pharm Sin B. 2021 Nov;11(11):3622-3635. doi: 10.1016/j.apsb.2021.06.001. Epub 2021 Jun 8.
Acta Pharm Sin B. 2021.
PMID: 34900541
Free PMC article.